Filing Details
- Accession Number:
- 0001209191-20-053346
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-10-02 18:42:47
- Reporting Period:
- 2020-09-25
- Accepted Time:
- 2020-10-02 18:42:47
- Original Submission Date:
- 2020-09-29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1699382 | Pmv Pharmaceuticals Inc. | PMVP | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1207833 | L Arnold Oronsky | C/O Pmv Pharmaceuticals, Inc. 8 Clarke Drive, Suite 3 Cranbury NJ 08512 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-25 | 55,555 | $18.00 | 55,555 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2020-09-29 | 1,620,101 | $0.00 | 1,675,656 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2020-09-29 | 3,488,398 | $0.00 | 5,164,054 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2020-09-29 | 1,040,654 | $0.00 | 6,204,708 | No | 4 | C | Indirect | See footnote |
| Common Stock | Acquisiton | 2020-09-29 | 265,203 | $0.00 | 6,469,911 | No | 4 | C | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
| No | 4 | C | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series Seed Preferred Stock | Disposition | 2020-09-29 | 1,620,101 | $0.00 | 1,620,101 | $0.00 |
| Common Stock | Series A Preferred Stock | Disposition | 2020-09-29 | 3,488,398 | $0.00 | 3,488,398 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2020-09-29 | 1,040,654 | $0.00 | 1,040,654 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2020-09-29 | 265,203 | $0.00 | 265,203 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The shares are directly held by InterWest Partners X, LP ("InterWest X"). InterWest Management Partners X, LLC ("IMP X"), as the general partner of InterWest X, may be deemed to beneficially own the shares held by InterWest X. The Reporting Person is a managing director of IMP X, and as such may be deemed to beneficially own the shares held by InterWest X. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- The shares of each of the Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date.
Billionaire Hedge Funds
